<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T22:24:32Z</responseDate>
  <request identifier="oai:figshare.com:article/34025398" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34025398</identifier>
        <datestamp>2026-09-29T17:21:32Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Associations between antidepressant class and individual antidepressant medications and special educational need.&lt;/p&gt;</dc:title>
          <dc:creator>Saraid McIlvride (11979735)</dc:creator>
          <dc:creator>Neha Rao (24389297)</dc:creator>
          <dc:creator>Sarjit Singh (6491816)</dc:creator>
          <dc:creator>Scott M. Nelson (8662176)</dc:creator>
          <dc:creator>Jill P. Pell (7783655)</dc:creator>
          <dc:creator>Michael Fleming (50815)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>norepinephrine reuptake inhibitors</dc:subject>
          <dc:subject>markedly different association</dc:subject>
          <dc:subject>level deprivation quintile</dc:subject>
          <dc:subject>adjusted odds ratio</dc:subject>
          <dc:subject>adjusted hazard ratio</dc:subject>
          <dc:subject>447 children born</dc:subject>
          <dc:subject>0 per 100</dc:subject>
          <dc:subject>individual antidepressant classes</dc:subject>
          <dc:subject>antidepressant medication without</dc:subject>
          <dc:subject>antidepressant class showed</dc:subject>
          <dc:subject>antidepressants may confer</dc:subject>
          <dc:subject>although tricyclic antidepressants</dc:subject>
          <dc:subject>meanwhile antidepressant use</dc:subject>
          <dc:subject>recorded depression diagnosis</dc:subject>
          <dc:subject>antidepressant medication exposure</dc:subject>
          <dc:subject>xlink "&gt; offspring</dc:subject>
          <dc:subject>3 per 100</dc:subject>
          <dc:subject>quantify absolute risk</dc:subject>
          <dc:subject>mothers without depression</dc:subject>
          <dc:subject>mean age 5</dc:subject>
          <dc:subject>prenatal maternal depression</dc:subject>
          <dc:subject>antidepressant use</dc:subject>
          <dc:subject>antidepressant exposure</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>630 children</dc:subject>
          <dc:subject>0 ])).</dc:subject>
          <dc:subject>prenatal exposure</dc:subject>
          <dc:subject>absolute risk</dc:subject>
          <dc:subject>antidepressant prescriptions</dc:subject>
          <dc:subject>maternal depression</dc:subject>
          <dc:subject>higher risk</dc:subject>
          <dc:subject>adhd diagnosis</dc:subject>
          <dc:subject>maternal age</dc:subject>
          <dc:subject>untreated depression</dc:subject>
          <dc:subject>treated depression</dc:subject>
          <dc:subject>depression severity</dc:subject>
          <dc:subject>depression alone</dc:subject>
          <dc:subject>two years</dc:subject>
          <dc:description>&lt;p&gt;&lt;b&gt;A.&lt;/b&gt; Generalized estimating equation (GEE) analysis; &lt;b&gt;B.&lt;/b&gt; Cox proportional hazards analysis of associations between antidepressants and ADHD. Odds ratios/hazard ratios and 95% confidence intervals shown, for children exposed to treated depression compared to unexposed. Adjusted for sex, deprivation quintile, ethnicity, age, maternal age, maternal smoking status, parity, multiple birth and maternal epilepsy. For ADHD, ethnicity was collapsed into 4 categories (White; Black/Asian/Mixed; Other; Missing). SEN, special educational need; ASD, autism spectrum disorder; PMED, physical and medical difficulties; BES, behavioral-emotional-social; ADHD, attention deficit hyperactivity disorder; SSRIs, selective serotonin reuptake inhibitors; TCAs, tricyclic antidepressants; TeCAs, tetracyclic antidepressants; SNRIs, serotonin and norepinephrine reuptake inhibitors.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T17:21:22Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pmed.1004658.g001</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Associations_between_antidepressant_class_and_individual_antidepressant_medications_and_special_educational_need_p_/34025398</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
